Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
1.6550
-0.0550
(-3.23%)
As of 11:02:53 AM EST. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 4 | 3 | 3 |
| Avg. Estimate | -0.04 | -0.03 | -0.12 | -0.04 |
| Low Estimate | -0.04 | -0.04 | -0.14 | -0.05 |
| High Estimate | -0.03 | -0.02 | -0.11 | -0.02 |
| Year Ago EPS | -0.09 | -0.1 | -0.27 | -0.12 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 8 | 8 |
| Avg. Estimate | 49.88M | 54.98M | 235.46M | 378.56M |
| Low Estimate | 46.96M | 48.03M | 209.68M | 265.93M |
| High Estimate | 54.3M | 62.3M | 266.3M | 448.2M |
| Year Ago Sales | 304k | 882k | 76.99M | 235.46M |
| Sales Growth (year/est) | 16,309.12% | 6,133.43% | 205.82% | 60.77% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.09 | -0.1 | -0.08 | -0.05 |
| EPS Actual | -0.09 | -0.1 | -0.04 | -0.04 |
| Difference | 0 | 0 | 0.04 | 0.01 |
| Surprise % | 3.57% | 1.57% | 50.09% | 23.28% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.04 | -0.03 | -0.12 | -0.04 |
| 7 Days Ago | -0.04 | -0.02 | -0.07 | 0.14 |
| 30 Days Ago | -0.04 | -0.02 | -0.07 | 0.16 |
| 60 Days Ago | -0.03 | -0.02 | -0.06 | 0.22 |
| 90 Days Ago | -0.04 | -0.02 | -0.05 | 0.23 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | 1 | 1 | -- |
| Down Last 7 Days | 1 | 1 | 1 | 1 |
| Down Last 30 Days | 1 | 1 | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GERN | 60.37% | 69.50% | 53.29% | 72.00% |
| S&P 500 | 16.04% | 7.30% | 10.63% | 14.23% |
Upgrades & Downgrades
| Maintains | Scotiabank: Sector Outperform to Sector Outperform | 2/27/2025 |
| Maintains | Stifel: Buy to Buy | 2/27/2025 |
| Maintains | Barclays: Overweight to Overweight | 2/27/2025 |
| Maintains | Needham: Buy to Buy | 2/27/2025 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 2/26/2025 |
| Maintains | B. Riley Securities: Buy to Buy | 2/18/2025 |
Related Tickers
IOVA Iovance Biotherapeutics, Inc.
3.8150
-5.57%
LXRX Lexicon Pharmaceuticals, Inc.
0.3222
+10.12%
ENVB Enveric Biosciences, Inc.
2.2250
-14.42%
MDGL Madrigal Pharmaceuticals, Inc.
309.06
-1.41%
IBRX ImmunityBio, Inc.
2.8450
-0.18%
TGTX TG Therapeutics, Inc.
36.06
+4.75%
BTAI BioXcel Therapeutics, Inc.
2.7185
-27.64%
MBRX Moleculin Biotech, Inc.
1.0200
-11.30%
PEPG PepGen Inc.
2.0650
-26.51%
ONVO Organovo Holdings, Inc.
0.6200
-11.44%